文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

超声内镜引导下胆管十二指肠吻合术采用管腔并置支架对比内镜逆行胰胆管造影术采用覆膜金属支架治疗不可切除恶性远端胆道梗阻患者的多中心随机对照试验(DRA-MBO试验)

EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial).
PubMed 文献 · Gastroenterology · 2023-04-28

本研究为多中心国际随机对照试验,纳入155例不可切除恶性远端胆道梗阻所致梗阻性黄疸患者,随机接受超声内镜引导下胆管十二指肠吻合术(ECDS)或内镜逆行胰胆管造影术(ERCP)引流。主要结局1年支架通畅率两组无显著差异(ECDS 91.1% vs ERCP 88.1%,P=.52),ECDS组技术成功率显著更高(96.2% vs 76.3%,P<.001),操作时间显著更短(中位10 vs 25分钟,P<.001)。结论认为两种术式均可作为一线胆道引流选择,ECDS技术成功率高且操作时间短,预计ERCP困难时可优先考虑ECDS。

要点

  • 1年支架通畅率ECDS 91.1% vs ERCP 88.1%,无显著差异(P=.52)。
  • 技术成功率ECDS 96.2% vs ERCP 76.3%,ECDS显著更高(P<.001)。
  • 中位操作时间ECDS 10分钟 vs ERCP 25分钟,ECDS显著更短(P<.001)。

核心结论

  • 两种术式均可作为不可切除恶性远端胆道梗阻的一线胆道引流选择,ECDS技术成功率更高且操作时间更短,预计ERCP困难时可优先考虑ECDS。

研究设计与样本

  • 多中心国际随机对照试验,2017年1月至2021年2月连续纳入因不可切除恶性远端胆道梗阻致梗阻性黄疸的患者155例,随机分配至ECDS组79例或ERCP组76例。

主要发现

  • 1年支架通畅率ECDS组91.1% vs ERCP组88.1%,无显著差异(P=.52)。
  • 技术成功率ECDS组96.2% vs ERCP组76.3%,ECDS组显著更高(P<.001)。
  • 临床成功率ECDS组93.7% vs ERCP组90.8%,无显著差异(P=.559)。
  • 中位(四分位距)操作时间ECDS组10(5.75-18)分钟 vs ERCP组25(14-40)分钟,ECDS组显著更短(P<.001)。
  • 30天不良事件发生率(P=1)与30天死亡率(P=.53)两组相似。

临床怎么用

  • 作者认为两种术式均可作为不可切除恶性远端胆道梗阻的一线胆道引流选择。
  • 作者认为ECDS技术成功率更高且操作时间更短,预计ERCP困难时可优先考虑ECDS。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Several studies have compared primary endoscopic ultrasound (EUS)-guided biliary drainage to endoscopic retrograde cholangiopancreatography (ERCP) with insertion of metal stents in unresectable malignant distal biliary obstruction (MDBO) and the results were conflicting. The aim of the current study was to compare the outcomes of the procedures in a large-scale study. METHODS: This was a multicenter international randomized controlled study. Consecutive patients admitted for obstructive jaundice due to unresectable MDBO were recruited. Patients were randomly allocated to receive EUS-guided choledocho-duodenostomy (ECDS) or ERCP for drainage. The primary outcome was the 1-year stent patency rate. Other outcomes included technical success, clinical success, adverse events, time to stent dysfunction, reintervention rates, and overall survival. RESULTS: Between January 2017 and February 2021, 155 patients were recruited (ECDS 79, ERCP 76). There were no significant differences in 1-year stent patency rates (ECDS 91.1% vs ERCP 88.1%, P = .52). The ECDS group had significantly higher technical success (ECDS 96.2% vs ERCP 76.3%, P < .001), whereas clinical success was similar (ECDS 93.7% vs ERCP 90.8%, P = .559). The median (interquartile range) procedural time was significantly shorter in the ECDS group (ECDS 10 [5.75-18] vs ERCP 25 [14-40] minutes, P < .001). The rate of 30-day adverse events (P = 1) and 30-day mortality (P = .53) were similar. CONCLUSION: Both procedures could be options for primary biliary drainage in unresectable MDBO. ECDS was associated with higher technical success and shorter procedural time then ERCP. Primary ECDS may be preferred when difficult ERCPs are anticipated. This study was registered to Clinicaltrials.gov NCT03000855.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Teoh AYB, Napoleon B, Kunda R, et al. EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial). Gastroenterology. 2023. PMID: 37121331. doi:10.1053/j.gastro.2023.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。